Suzie Trigg

Practices

Industries

Trending Issues

Education and Clerkships

J.D., University of Texas at Austin School of Law, 2006, with honors, Texas Environmental Law Journal

B.S., Animal Science, Texas A&M University, 2003

  • The Honorable Brian L. Owsley, U.S. Magistrate Judge for the Southern District of Texas
  • Institute for Food Laws and Regulations, Michigan State University

Admissions

Texas, 2006

Profile

Suzie Trigg guides companies through FDA regulatory matters, high-stakes supply chain transactions, and strategic growth. She leverages her unique experience to help companies negotiate and document transactions and make well-informed decisions to address their complex FDA regulatory requirements. She holds leadership positions in the firm’s Healthcare and Life Sciences Practice Group, and its Food, Beverage and Restaurant Practice Group.

Suzie is a go-to lawyer for companies tackling critical supply chain challenges, having been lead outside counsel for, among others, a 7,500+ store retailer negotiating supply chain agreements for transactions valued at more than $25 billion over five years. Her recent work also includes:

  • Facilitating investigations and analyses of high-stakes food safety and other product concerns, including both preventive gap analyses and analyzing specific events to determine FDA regulatory obligations and to chart a long-term course of action to correct and prevent re-occurrence of the potential concerns
  • Preparing and implementing supplier standards and supply chain agreements for multiple global restaurant chains
  • Developing and negotiating commercial agreements and quality agreements for the manufacture, supply, and distribution of both branded and private label foods, cosmetics, dietary supplements, and over-the-counter drugs

Suzie helps companies lawfully market their products by reviewing the use of specific ingredients and by reviewing product claims made on labels or in advertising. Her experience in this area includes foods, dietary supplements, cosmetics, personal care products, and over-the-counter drugs. She frequently provides advice and guidance on strategies intended to reduce the risk of a demand, class action, or regulatory enforcement.

While much of her work focuses on designing strategies to minimize risk and avoid costly delays or setbacks, Suzie also helps companies thoroughly and efficiently address obstacles, such as potential FDA enforcement actions, potential product recalls, and disputes with distributors or other supply chain partners.

Given Suzie’s experience, she often leads due diligence of FDA regulated companies in connection with a potential merger or acquisition and addresses issues critical to deal closure. Suzie has also conducted due diligence for potential underwriters of securities offerings by emerging pharmaceutical, medical device, and biologic companies.

Suzie is in her third year of serving on FDLI’s Food Advertising and Litigation Conference Planning Committee. She previously served on FDLI’s Food and Dietary Supplements Committee and FDLI’s Writing Awards Committee. 

Newsletter

Health Law Vitals

Health Law Vitals - A Healthcare Newsletter from Haynes and Boone

The Haynes and Boone Health Law Vitals Newsletter explores significant developments and legislation in healthcare law. This edition discusses the fiduciary duties of directors in medical technology, the promises and pitfalls of telehealth, the FDA's expansion of the Abbreviated 510(k) pathway, and more.

Honors

Super Lawyers

Haynes and Boone Lawyers Selected as Texas Rising Stars 2018

Texas Super Lawyers Rising Stars 2018, published by Thomson Reuters, has recognized 35 Haynes and Boone lawyers as up-and-coming practitioners in the state.

Selected Publications and Speeches

  • “Labeling Claims – Marketing Ideals vs. Regulation,” speaker, Texas Food Processors Association (TFPA) Annual Conference, San Antonio, Texas, May 16, 2019.
  • ""Sugar" and "Natural" Food Label Claims and Litigation – What’s Next?" speaker, FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law, Washington, D.C., May 2019.
  • “Containing Imported Food Contaminants to Protect Supply Chain Integrity,” speaker, ACI Third Annual Advanced Summit on Food Law – Regulation, Compliance and Litigation, Chicago, Illinois, April 2019.
  • “Reading the Tea Leaves for Dietary Supplements – FDA’s Current Enforcement Priorities and Actions,” presenter, FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law, May 2018.
  • "The Not So Sweet Side of Sugar," presenter, Institute of Food Technologists, Longhorn Section, Dallas, Texas, April 20, 2017.
  • “Menu Labeling – Cheese Fries for 700 Calories, Please,” speaker, 39th Annual ABA Forum on Franchising, Miami, Florida, November 2016.
  • "Food Labeling and Content Claims: Planning Ahead for the Updated Nutrition Facts Requirements," speaker, Food and Drug Law Institute Annual Conference, Washington, DC., May 2016.
  • "The Revised Nutrition Facts Panel and Update on Labeling of Foods from Genetically Engineered Plants," presenter, Institute of Food Technologists, Longhorn Section, Dallas, Texas, January 2016.
  • "Recent Developments in Food and Drug Law, 2016 ed.: Leading Lawyers on Dealing with Increased Enforcement, Keeping Up-To-Date with FDA Requirements, and Developing Compliance Practices," speaker, Inside the Minds, February 2016.
  • "Highlights of China’s 2015 Food Safety Law,” author, Law360, July 2015.
  • “Cosmetics Claims: Origin and Composition, Natural, and Fragrance-Free,” Food and Drug Law Institute webinar, June 2015.
  • “What’s Next for Labeling of Plant-Based Substitute [Foods],” speaker, Food and Drug Law Institute Annual Conference, Washington, D.C., April 2015.
  • "Meaningful Audit Systems,” speaker, FDLI Conference on Safeguarding the Functional Food and Dietary Ingredient Supply Chain, Washington, D.C., September 2013.
  • “Building an Effective Supply Chain and Distribution System,” speaker, 35th Annual ABA Forum on Franchising, Los Angeles, California, November 2012.

Intellectual Property

IP Beacon Year in Review 2018

The Intellectual Property Law 2018 Year In Review

We are pleased to highlight some of our representative intellectual property-related client successes and publications over the past year that might be relevant to your business success in the coming year. We represented clients in 74 inter partes review/PTAB proceedings that were filed in 2018, and our patent prosecution team filed over 2,300 U.S. patent applications and helped issue more than 1,650 U.S. patents just in 2018. We also helped close the IP issues in dozens of financings, M&A transactions, and joint venture/licensing arrangements.

Professional Recognition

  • Selected for inclusion in Texas Super Lawyers Rising Stars, Thomson Reuters, 2016-2019
  • Recognized in D Magazine's "Best Lawyers in Dallas," D Magazine Partners, 2018
  • Selected as Best in Supply Chain Negotiations – USA, Acquisition International 2015 Legal Awards, AI Global Media Ltd, 2015; Best in Supply Chain Management Disputes - Texas, 2017

Healthcare

Healthcare

FDA Announces Plan to Increase Oversight of Dietary Supplements

The FDA’s recent statement unveiling its goal to implement “one of the most significant modernizations of dietary supplement regulation and oversight in more than 25 years” emphasizes FDA Commissioner Scott Gottlieb’s continued focus on enforcement against unlawful activities – including product promotions and advertising – that create substantial public health risk.

Email Disclaimer